High-Profile Forum on Sino-European Drug Registration and IPRs Held Successfully

来源:商学院发稿时间:2016-05-05浏览次数:30

  On April 20th, 2016, High-Profile Forum on Sino-European Drug Registration and IPRs was held in Report Hall 111 of Economics & Arts Building, China Pharmaceutical University. Seven experts from both home and abroad delivered special reports, concentrating on current hot topics on drug registration and IPRs. Over 200 professionals and students attended the forum.     
  Supported by “Funded Program of College Brand-Name Specialties Construction Project of Jiangsu Province”, the forum belongs to the 15th Part of “ Series of Lectures of New Horizon of International Medicine” , which is undertaken by School of International Pharmaceutical Business,China Pharmaceutical University.

  

  A Report by Dr.Nick Beckett, CMS UK.

 A Report by Dr.Markus Deck, Patent and Trademark Office, Dusseldorf, Germany.

  A Report by Dr. Anton Bankovskiy, CMS Russia.

 A Report by Sun Lifang, IPRs Director of Luye Pharma, China.

  

A Report by Sun Liming, IPRs Director of Qilu Pharma, China.

A Report by Geng Wenjun, IPRs Director of Chia-Tai Tiangqing Pharma, China.

A Report by Prof. Ding Jingxi, China Pharmaceutical University.  

The Scene of the Forum